Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 48

1.

25-Hydroxyvitamin D Inhibits Hepatitis C Virus Production in Hepatocellular Carcinoma Cell Line by a Vitamin D Receptor-Independent Mechanism.

Ravid A, Rapaport N, Issachar A, Erman A, Bachmetov L, Tur-Kaspa R, Zemel R.

Int J Mol Sci. 2019 May 13;20(9). pii: E2367. doi: 10.3390/ijms20092367.

2.

Correction: Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography.

Shteyer E, Shekhtman L, Zinger T, Harari S, Gafanovich I, Wolf D, Ivgi H, Barsuk R, Dery I, Armoni D, Rivkin M, Pipalia R, Eliav MC, Skorochod Y, Breuer GS, Tur-Kaspa R, Wiener YW, Stern A, Cotler SJ, Dahari H, Lurie Y.

PLoS One. 2019 Feb 7;14(2):e0212252. doi: 10.1371/journal.pone.0212252. eCollection 2019.

3.

Modeling suggests that microliter volumes of contaminated blood caused an outbreak of hepatitis C during computerized tomography.

Shteyer E, Shekhtman L, Zinger T, Harari S, Gafanovich I, Wolf D, Ivgi H, Barsuk R, Dery I, Armoni D, Rivkin M, Pipalia R, Cohen Eliav M, Skorochod Y, Breuer GS, Tur-Kaspa R, Weil Wiener Y, Stern A, Cotler SJ, Dahari H, Lurie Y.

PLoS One. 2019 Jan 15;14(1):e0210173. doi: 10.1371/journal.pone.0210173. eCollection 2019. Erratum in: PLoS One. 2019 Feb 7;14(2):e0212252.

4.

Transplantation of Livers from Old Donors: Pushing the Envelope Beyond the Seventh Decade.

Nesher E, Braun M, Eizner S, Issachar A, Cohen M, Shlomai A, Gurevich M, Tur-Kaspa R, Mor E.

Isr Med Assoc J. 2018 Dec;20(12):765-769.

5.

The utility of magnetic resonance cholangiopancreatography for the assessment of patients with elevated liver enzyme levels.

Benjaminov O, Bachar GN, Goldberg N, Benjaminov-Sclarovsky F, Tur-Kaspa R.

Eur J Gastroenterol Hepatol. 2013 Oct;25(10):1190-4. doi: 10.1097/MEG.0b013e328360762e.

PMID:
24002015
6.

[Israeli guidelines for the treatment of chronic hepatitis C infection--2012 Israeli Association for the Study of the Liver].

Zuckerman E, Safadi R, Oren R, Shibolet O, Baruch Y, Bruck R, Lurei Y, Kaspa RT, Abu-Mouch S, Shouval D, Ben-Ari Z; Israeli Association for the Study of the Liver.

Harefuah. 2012 Dec;151(12):709-14, 719. Hebrew.

PMID:
23330266
7.

The use of epitope arrays in immunodiagnosis of infectious disease: hepatitis C virus, a case study.

Siman-Tov DD, Zemel R, Tur Kaspa R, Gershoni JM.

Anal Biochem. 2013 Jan 15;432(2):63-70. doi: 10.1016/j.ab.2012.09.025. Epub 2012 Sep 24.

PMID:
23017878
8.

Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.

Katz LH, Goldvaser H, Gafter-Gvili A, Tur-Kaspa R.

Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008516. doi: 10.1002/14651858.CD008516.pub2. Review.

PMID:
22972122
9.

Removal of hepatitis C virus-infected cells by a zymogenized bacterial toxin.

Shapira A, Shapira S, Gal-Tanamy M, Zemel R, Tur-Kaspa R, Benhar I.

PLoS One. 2012;7(2):e32320. doi: 10.1371/journal.pone.0032320. Epub 2012 Feb 16.

10.

Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes.

Gal-Tanamy M, Bachmetov L, Ravid A, Koren R, Erman A, Tur-Kaspa R, Zemel R.

Hepatology. 2011 Nov;54(5):1570-9. doi: 10.1002/hep.24575.

PMID:
21793032
11.

The role of oncogenic viruses in the pathogenesis of hepatocellular carcinoma.

Zemel R, Issachar A, Tur-Kaspa R.

Clin Liver Dis. 2011 May;15(2):261-79, vii-x. doi: 10.1016/j.cld.2011.03.001. Review.

PMID:
21689612
12.

Engineered toxins "zymoxins" are activated by the HCV NS3 protease by removal of an inhibitory protein domain.

Shapira A, Gal-Tanamy M, Nahary L, Litvak-Greenfeld D, Zemel R, Tur-Kaspa R, Benhar I.

PLoS One. 2011 Jan 14;6(1):e15916. doi: 10.1371/journal.pone.0015916.

13.

Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies.

Gal-Tanamy M, Zemel R, Bachmatov L, Jangra RK, Shapira A, Villanueva RA, Yi M, Lemon SM, Benhar I, Tur-Kaspa R.

Antiviral Res. 2010 Oct;88(1):95-106. doi: 10.1016/j.antiviral.2010.08.001. Epub 2010 Aug 10.

14.

Lamivudine or adefovir dipivoxil alone or combined with immunoglobulin for preventing hepatitis B recurrence after liver transplantation.

Katz LH, Tur-Kaspa R, Guy DG, Paul M.

Cochrane Database Syst Rev. 2010 Jul 7;(7):CD006005. doi: 10.1002/14651858.CD006005.pub2. Review.

PMID:
20614442
15.

Farglitazar lacks antifibrotic activity in patients with chronic hepatitis C infection.

McHutchison J, Goodman Z, Patel K, Makhlouf H, Rodriguez-Torres M, Shiffman M, Rockey D, Husa P, Chuang WL, Levine R, Jonas M, Theodore D, Brigandi R, Webster A, Schultz M, Watson H, Stancil B, Gardner S; Farglitizar Study Investigators.

Gastroenterology. 2010 Apr;138(4):1365-73, 1373.e1-2. doi: 10.1053/j.gastro.2009.12.003. Epub 2010 Feb 13. Erratum in: Gastroenterology. 2010 Jul;139(1):360.

PMID:
20004661
16.

A comparison of transjugular and plugged-percutaneous liver biopsy in patients with contraindications to ordinary percutaneous liver biopsy and an "in-house" protocol for selecting the procedure of choice.

Atar E, Ben Ari Z, Bachar GN, Amlinski Y, Neyman C, Knizhnik M, Litvin S, Schmilovitz-Weiss H, Shapiro R, Bruckhaimer E, Tur-Kaspa R, Belenky A.

Cardiovasc Intervent Radiol. 2010 Jun;33(3):560-4. doi: 10.1007/s00270-009-9743-z. Epub 2009 Nov 12.

PMID:
19908088
17.

Bezafibrate treatment of primary biliary cirrhosis following incomplete response to ursodeoxycholic acid.

Hazzan R, Tur-Kaspa R.

J Clin Gastroenterol. 2010 May-Jun;44(5):371-3. doi: 10.1097/MCG.0b013e3181c115b3.

PMID:
19881358
18.

Expression of liver-specific markers in naïve adipose-derived mesenchymal stem cells.

Zemel R, Bachmetov L, Ad-El D, Abraham A, Tur-Kaspa R.

Liver Int. 2009 Oct;29(9):1326-37. doi: 10.1111/j.1478-3231.2009.02054.x. Epub 2009 Jun 5.

PMID:
19515222
19.

Postshunt hepatic encephalopathy in liver transplant recipients.

Braun MM, Bar-Nathan N, Shaharabani E, Aizner S, Tur-Kaspa R, Belenky A, Mor E, Ben-Ari ZZ.

Transplantation. 2009 Mar 15;87(5):734-9. doi: 10.1097/TP.0b013e318196340d.

PMID:
19295319
20.

Hepatitis C virus targets over-expression of arginase I in hepatocarcinogenesis.

Cao W, Sun B, Feitelson MA, Wu T, Tur-Kaspa R, Fan Q.

Int J Cancer. 2009 Jun 15;124(12):2886-92. doi: 10.1002/ijc.24265.

Supplemental Content

Loading ...
Support Center